866-897-8297

Call Is Confidential & Toll Free

Eliquis

Eliquis is an oral, direct, and highly selective factor Xa (FXa) inhibitor (of both free and prothrombinase-bound FXa independently of antithrombin III ) for the prevention and treatment of thromboembolic diseases. It is marketed under the name Eliquis. FDA approved on December 28, 2012.

Eliquis acts by inhibiting coagulation, and thus prevents development of blood clots. As a result of FXa inhibition, eliquis prolongs clotting tests such as prothrombin time (PT), INR, and activated partial thromboplastin time (aPTT). Changes observed in these clotting tests at the expected therapeutic dose, however, are small, subject to a high degree of variability, and not useful in monitoring the anticoagulation effect of eliquis. The Rotachrom® Heparin chromogenic assay is not recommended for assessing the anticoagulant effect of eliquis.

Major bleeding events.

Imprints


Drug: Eliquis
Strength: 5 Mg
Pill Imprint: 894 5
Color: Pink
Shape: Elliptical / Oval

View Images & Details

Drug: Eliquis
Strength: 2.5 Mg
Pill Imprint: 893 2 1/2
Color: Yellow
Shape: Round

View Images & Details
Disclaimer: We strive to ensure that the content on pilladdictions.com is current and factual at the time it was written. However, because new information and discoveries are always becoming available, we are not making any representations or warranties with respect to this content. Please always rely on the guidance of your physician for information about the drugs you are taking and the impacts they may or may not have on your health.

Questions About Prescription Drug Addiction?

(888) 740-2069

Questions About Prescription Drug Addiction?